Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.6945
-0.0055 (-0.79%)
At close: Aug 7, 2025, 4:00 PM
0.7272
+0.0327 (4.71%)
Pre-market: Aug 8, 2025, 4:11 AM EDT
CALT Market Cap
Iterum Therapeutics has a market cap or net worth of $29.26 million as of August 7, 2025. Its market cap has increased by 44.62% in one year.
Market Cap
29.26M
Enterprise Value
48.79M
1-Year Change
44.62%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $29.26M, a decrease of -83.69%. That is a compound annual growth rate of -22.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 29.49M | -39.45% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | 48.54M | -27.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.35B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |